We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of ther... Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.28 | -9.52380952381 | 2.94 | 3.04 | 2.6231 | 96141 | 2.84048726 | CS |
4 | -0.11 | -3.97111913357 | 2.77 | 3.6 | 2.55 | 654285 | 3.07792125 | CS |
12 | -0.49 | -15.5555555556 | 3.15 | 5.9299 | 2.52 | 364475 | 3.47335457 | CS |
26 | -1.268 | -32.2810590631 | 3.928 | 9.374 | 2.52 | 2057908 | 4.914321 | CS |
52 | -0.94 | -26.1111111111 | 3.6 | 9.374 | 2.52 | 2219946 | 4.52308549 | CS |
156 | -90.14 | -97.1336206897 | 92.8 | 102.3 | 2.318 | 1137559 | 18.37666831 | CS |
260 | -77.34 | -96.675 | 80 | 390.8 | 2.318 | 978744 | 62.19184079 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions